Research on thyroid cancer detailed by scientists at Mayo Clinic
2009 AUG 3 - (NewsRx.com) -- "Papillary thyroid carcinoma is the most common endocrine malignancy. Recently, controversy has focused on the management of lymph node metastases, which represent approximately 90% of disease recurrences and may require considerable time, effort, and resources to diagnose and treat," scientists in the United States report. "Current intense postoperative surveillance by endocrinologists nationwide has the sensitivity to detect even minute lymph node metastases using ultrasonography, radioactive iodine scan, and thyroglobulin monitoring. To (1) present a succinct synopsis of the rationale and elements of our current surgical management strategy for papillary thyroid carcinoma and, within this context, (2) provide a detailed stepwise description of a compartment-oriented modified radical neck dissection. This description is combined with intraoperative photographs and a medical artist's illustrations to enhance and emphasize the most important points," wrote J.R. Porterfield and colleagues, Mayo Clinic. The researchers concluded: "With anatomically defined precise dissection, following the steps outlined and illustrated, a thorough lymphadenectomy can be accomplished safely, with reasonable cosmetic results, minimizing disease relapse.." Porterfield and colleagues published their study in Archives of Surgery (Operative Technique for Modified Radical Neck Dissection in Papillary Thyroid Carcinoma. Archives of Surgery, 2009;144(6):567-574). For more information, contact C.S. Grant, Mayo Clinic, Dept. of Surgery, 200 1st St. SW, Rochester, MN 55905, USA. Publisher contact information for the journal Archives of Surgery is: American Medical Association, 515 N State St., Chicago, IL 60610-0946, USA. Keywords: United States, Rochester, Drugs, Endocrine, Oncology, Papillary Thyroid Cancer, Pharmaceuticals, Surgery, Therapy, Thyroglobulin, Thyroid Carcinoma, Treatment, Mayo Clinic. This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.
|
